Fournier J M, Jolivet-Reynaud C, Riottot M M, Jouin H
Infect Immun. 1981 May;32(2):420-6. doi: 10.1128/iai.32.2.420-426.1981.
Cell surface preparations and ribosomal preparations were extracted from Klebsiella pneumoniae. Agar gel diffusion with antisera to cell surface preparations or ribosomal preparations indicated common antigenic components among the preparations. Lipopolysaccharide and capsular polysaccharide were identified in the cell surface preparations. These results and the previous identification of lipopolysaccharide and capsular polysaccharide in ribosomal preparations suggest that these antigens are responsible for the immunochemical cross-reactivity observed among these two bacterial extracts. Active protection could be induced in mice by these two preparations. On a dry-weight basis, cell surface preparations provided better immunoprotective activity than did ribosomal preparations. However, the 50% protective dose of both preparations is practically the same on the basis of their capsular polysaccharide content. These results are consistent with the hypothesis that the immunoprotective moiety of ribosomal preparations is the contaminating cell surface antigens. Furthermore, the low level of nucleotidic components detected in purified cell surface preparations led us to infer that the immunoprotective activity of capsular polysaccharide may not be dependent on the adjuvant activity of ribonucleic acid. The involvement of capsular polysaccharide in the immunoprotective capacity of cell surface preparations is demonstrated either by using a degradation of this antigen by K. pneumoniae bacteriophage K2-associated glycanase or by using a preparation extracted from a noncapsulated mutant of K. pneumoniae. Nevertheless, the low protective ability of purified capsular polysaccharides is in contrast to its greater activity when induced in bacterial cell surface preparations. The protective activity of K. pneumoniae capsular polysaccharide may be dependent on its association with other surface antigenic components present in cell surface preparations or may be dependent on its native form in the bacterial cell surface.
从肺炎克雷伯菌中提取细胞表面制剂和核糖体制剂。用针对细胞表面制剂或核糖体制剂的抗血清进行琼脂凝胶扩散试验,结果表明这些制剂中存在共同的抗原成分。在细胞表面制剂中鉴定出脂多糖和荚膜多糖。这些结果以及之前在核糖体制剂中鉴定出脂多糖和荚膜多糖表明,这些抗原是这两种细菌提取物之间观察到的免疫化学交叉反应的原因。这两种制剂均可在小鼠中诱导出主动保护作用。以干重计,细胞表面制剂比核糖体制剂具有更好的免疫保护活性。然而,根据它们的荚膜多糖含量,两种制剂的50%保护剂量实际上是相同的。这些结果与核糖体制剂的免疫保护部分是污染的细胞表面抗原这一假设一致。此外,在纯化的细胞表面制剂中检测到的核苷酸成分水平较低,这使我们推断荚膜多糖的免疫保护活性可能不依赖于核糖核酸的佐剂活性。通过使用肺炎克雷伯菌噬菌体K2相关聚糖酶降解该抗原或使用从肺炎克雷伯菌的无荚膜突变体中提取的制剂,证明了荚膜多糖参与细胞表面制剂的免疫保护能力。然而,纯化的荚膜多糖的低保护能力与其在细菌细胞表面制剂中诱导时的较高活性形成对比。肺炎克雷伯菌荚膜多糖的保护活性可能取决于其与细胞表面制剂中存在的其他表面抗原成分的结合,或者可能取决于其在细菌细胞表面的天然形式。